28 results
6-K
EX-99.1
GMAB
Genmab
2 May 24
Genmab Announces Financial Results for the First Quarter of 2024
11:08am
and Tivdak that we received in the first quarter are important events that support our commitment to continue to deliver innovative treatment options
6-K
EX-99.1
GMAB
Genmab
15 Feb 24
Notice to Convene the Annual General Meeting of Genmab A/S
7:23pm
), the extent of the duties performed and the expected time commitment of the role. The fixed annual base fee as well as the supplemental annual fee per
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
. The patient perspective is paramount to innovation in research and development (R&D) and scientific advancement. Genmab's commitment to creating … . In 2023, Genmab colleagues participated in events that demonstrate our commitment and put our words into action. The Light the Night walk, a fundraising
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
) and scientific advancement. Genmab’s commitment to creating a meaningful difference is exemplified through our unwavering focus on understanding the unique … experiences and stories that shape the patient journey. In 2023, Genmab colleagues participated in events that demonstrate our commitment and put our
6-K
EX-99.1
egld cx244
25 Sep 23
Current report (foreign)
8:53am
6-K
EX-99.1
0bujdl88v7tspwt
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
xnkgshlvbmc9m8aodm4f
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
lj6aa1p
9 Mar 21
Notice to Convene the Annual General Meeting of Genmab A/S
9:25am
6-K
EX-99.1
0cs4ggn faw
23 Feb 21
Genmab 2020 Annual Report
12:38pm
6-K
EX-99.1
gbxyzg94262boq460z08
23 Feb 21
Genmab 2020 Annual Report
12:38pm
20-F
0q8 yr7m19thgaamxvr
30 Mar 20
Annual report (foreign)
5:12pm
6-K
EX-99.1
q94vtsdblxg3g6mku
10 Mar 20
Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer
9:17am
6-K
EX-99.1
s16nboh f6
27 Feb 20
Notice to Convene the Annual General Meeting of Genmab A/S
3:48pm
6-K
EX-99.1
39oyahhuk3bgw 59yx16
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
424B4
shqw5ffdn uw
19 Jul 19
Prospectus supplement with pricing info
12:00am